Mubritinib

Suppliers

Names

[ Name ]:
Mubritinib

[Synonym ]:
Mubritinib (TAK 165)
UNII-V734AZP9BR
1-(4-{4-[(2-{(E)-2-[4-(Trifluoromethyl)phenyl]vinyl}-1,3-oxazol-4-yl)methoxy]phenyl}butyl)-1H-1,2,3-triazole
Mubritinib,TAK 165,TAK165
Oxazole, 4-[[4-[4-(1H-1,2,3-triazol-1-yl)butyl]phenoxy]methyl]-2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-
(E)-1-(4-(4-((2-(4-(trifluoromethyl)styryl)oxazol-4-yl)methoxy)phenyl)butyl)-1H-1,2,3-triazole
TAK 165
Mubritinib
cc-594
1H-1,2,3-triazole, 1-(4-(4-((2-((1E)-2-(4-(trifluoromethyl)phenyl)ethenyl)-4-oxazolyl)methoxy)phenyl)butyl)-
S2216_Selleck

Chemical & Physical Properties

[ Density]:
1.3±0.1 g/cm3

[ Boiling Point ]:
620.9±65.0 °C at 760 mmHg

[ Melting Point ]:
158.0 to 162.0 °C

[ Molecular Formula ]:
C₂₅H₂₃F₃N₄O₂

[ Molecular Weight ]:
468.471

[ Flash Point ]:
329.3±34.3 °C

[ Exact Mass ]:
468.177307

[ PSA ]:
65.97000

[ LogP ]:
5.91

[ Vapour Pressure ]:
0.0±1.8 mmHg at 25°C

[ Index of Refraction ]:
1.578

[ Storage condition ]:
Store at +4°C

Safety Information

[ RIDADR ]:
NONH for all modes of transport